These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6737001)

  • 1. A study of platelet protein phosphorylation in Duchenne muscular dystrophy. Further evidence against the generalised membrane defect theory.
    Nicholson GA; McLeod JG; Sugars JW
    J Neurol Sci; 1984 Apr; 64(1):21-32. PubMed ID: 6737001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet abnormalities in muscular dystrophy.
    Yarom R; Meyer S; More R; Liebergall M; Eldor A
    Thromb Haemost; 1983 Jun; 49(3):168-72. PubMed ID: 6308847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy.
    Roses AD; Appel SH
    J Neurol Sci; 1976 Oct; 29(2-4):185-93. PubMed ID: 978207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet intracellular calcium in patients with Duchenne muscular dystrophy.
    Lechi C; Sinigaglia D; Guzzo P; Bonadonna G; Zatti M
    Clin Chim Acta; 1988 Sep; 177(1):119-21. PubMed ID: 3180486
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased A23187-induced chemiluminescence in Duchenne muscular dystrophy granulocytes.
    Nicholson GA; Sugars J
    J Neurol Sci; 1982 Oct; 56(1):11-6. PubMed ID: 6815307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin uptake in blood platelets of Duchenne muscular dystrophy patients.
    Arora RC; Kuncl RW; Morgan J; Cohen L; Meltzer HY
    Muscle Nerve; 1987 May; 10(4):359-62. PubMed ID: 3587271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of fibroblast proteins from patients with Duchenne muscular dystrophy by two-dimensional gel electrophoresis.
    Rosenmann E; Kreis C; Thompson RG; Dobbs M; Hamerton JL; Wrogemann K
    Nature; 1982 Aug; 298(5874):563-5. PubMed ID: 10465679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor.
    Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ
    Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of water permeability and proteins of erythrocyte membranes in patients with Duchenne muscular dystrophy.
    Benga G; Popescu O; Pop VI; Ionescu I; Muresan A; Borza V; Hodârnău A; Popescu M; Serbu AM; Benga I
    Muscle Nerve; 1989 Apr; 12(4):294-301. PubMed ID: 2770782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrin extractability from erythrocytes in Duchenne muscular dystrophy patients and carriers and in other myopathies.
    Gargioni G; Chiaffoni G; Bonadonna G; Corradini P; Lechi C; de Grandis D; Zatti M
    Clin Chim Acta; 1985 Feb; 145(3):259-65. PubMed ID: 3987029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy.
    Roses AD; Herbstreith M; Metcalf B; Appel SH
    J Neurol Sci; 1976 Nov; 30(1):167-78. PubMed ID: 10352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte-ghost Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Duchenne muscular dystrophy.
    Dunn MJ; Burghes AH; Dubowitz V
    Biochem J; 1982 Mar; 201(3):445-53. PubMed ID: 6124239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of platelet glass bead adhesion and platelet membrane glycoprotein IV (CD36) in Duchenne muscular dystrophy.
    Maurin N; Forst J; Leithe H; Forst R
    Thromb Haemost; 1998 May; 79(5):1067. PubMed ID: 9609256
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative ELISA for platelet m-calpain: a phenotypic index for detection of carriers of Duchenne muscular dystrophy.
    Hussain T; Kumar DV; Sundaram C; Mohandas S; Anandaraj MP
    Clin Chim Acta; 1998 Jan; 269(1):13-20. PubMed ID: 9498100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of erythrocytes in Duchenne muscular dystrophy.
    Yoshida M; Ando K; Satoyoshi E
    Ann Neurol; 1983 Jun; 13(6):649-53. PubMed ID: 6881927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgery.
    Turturro F; Rocca B; Gumina S; De Cristofaro R; Mangiola F; Maggiano N; Evangelista A; Salsano V; Montanaro A
    Neuromuscul Disord; 2005 Aug; 15(8):532-40. PubMed ID: 16009551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage.
    Miike T; Sugino S; Ohtani Y; Taku K; Yoshioka K
    J Neurol Sci; 1987 Dec; 82(1-3):67-80. PubMed ID: 3440873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-dependent potassium transport in progressive muscular dystrophy.
    Szentistványi I; Janka Z; Heiner L
    Eur Neurol; 1980; 19(1):39-42. PubMed ID: 7371652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-activated neutral protease from muscle and platelets of Duchenne muscular dystrophy cases.
    Rabbani N; Moses L; Anandavalli TE; Anandaraj MP
    Clin Chim Acta; 1984 Nov; 143(2):163-8. PubMed ID: 6096040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
    Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.